Alkermes plc. Financing Cash Flow
Alkermes plc. (ALKS) reported Financing Cash Flow of $1.49 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-28
- Alkermes plc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $17.20M, a 4148.15% increase year-over-year.
- Alkermes plc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $1.47B, a 197292.10% increase year-over-year.
- Alkermes plc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $10.91M.
- Alkermes plc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $315.00K.
- Alkermes plc. net cash provided by (used in) financing activities for fiscal 2025 was $12.38M.
- Alkermes plc. net cash provided by (used in) financing activities for fiscal 2024 was -$494.14M.
- Alkermes plc. net cash provided by (used in) financing activities for fiscal 2023 was -$289.71M.
- Alkermes plc. net cash provided by (used in) financing activities for fiscal 2022 was -$1.57M, a 105.41% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $1.49B 10-Q · filed 2026-07-28 | $1.50B derived: sum of 3 quarters · filed 2026-07-28 | $1.50B derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $1.47B 10-Q · filed 2026-05-05 | $1.49B derived: sum of 2 quarters · filed 2026-05-05 | $1.49B derived: sum of 3 quarters · filed 2026-05-05 | $1.49B derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $10.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $11.23M derived: sum of 2 quarters · filed 2026-02-25 | $11.63M derived: sum of 3 quarters · filed 2026-07-28 | $12.38M 10-K · filed 2026-02-25 |
| 2025-09-30 | $315.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $720.00K derived: sum of 2 quarters · filed 2026-07-28 | $1.47M 10-Q · filed 2025-10-28 | -$280.20M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $405.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $1.15M 10-Q · filed 2026-07-28 | -$280.52M derived: sum of 3 quarters · filed 2026-07-28 | -$391.63M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $747.00K 10-Q · filed 2026-05-05 | -$280.92M derived: sum of 2 quarters · filed 2026-05-05 | -$392.04M derived: sum of 3 quarters · filed 2026-05-05 | -$475.52M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$281.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$392.78M derived: sum of 2 quarters · filed 2026-02-25 | -$476.27M derived: sum of 3 quarters · filed 2026-02-25 | -$494.14M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$111.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$194.60M derived: sum of 2 quarters · filed 2025-10-28 | -$212.47M 10-Q · filed 2025-10-28 | -$488.97M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$83.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$101.36M 10-Q · filed 2025-07-29 | -$377.85M derived: sum of 3 quarters · filed 2026-02-25 | -$376.29M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$17.87M 10-Q · filed 2025-05-01 | -$294.37M derived: sum of 2 quarters · filed 2026-02-25 | -$292.80M derived: sum of 3 quarters · filed 2026-02-25 | -$284.97M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$276.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$274.93M derived: sum of 2 quarters · filed 2026-02-25 | -$267.09M derived: sum of 3 quarters · filed 2026-02-25 | -$289.71M 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $9.40M derived: sum of 2 quarters · filed 2024-10-24 | -$13.22M 10-Q · filed 2024-10-24 | -$13.49M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $7.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | -$14.78M 10-Q · filed 2024-07-24 | -$15.05M derived: sum of 3 quarters · filed 2025-02-12 | -$15.27M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -$22.62M 10-Q · filed 2024-05-01 | -$22.89M derived: sum of 2 quarters · filed 2025-02-12 | -$23.10M derived: sum of 3 quarters · filed 2025-02-12 | -$8.17M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -$271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$483.00K derived: sum of 2 quarters · filed 2025-02-12 | $14.45M derived: sum of 3 quarters · filed 2025-02-12 | -$1.57M 10-K · filed 2025-02-12 |
| 2022-09-30 | -$212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $14.72M derived: sum of 2 quarters · filed 2023-10-25 | -$1.30M 10-Q · filed 2023-10-25 | -$4.48M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $14.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | -$1.09M 10-Q · filed 2023-07-26 | -$4.27M derived: sum of 3 quarters · filed 2024-02-21 | -$3.24M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$16.02M 10-Q · filed 2023-04-26 | -$19.20M derived: sum of 2 quarters · filed 2024-02-21 | -$18.17M derived: sum of 3 quarters · filed 2024-02-21 | -$1.90M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$2.15M derived: sum of 2 quarters · filed 2024-02-21 | $14.13M derived: sum of 3 quarters · filed 2024-02-21 | $29.07M 10-K · filed 2024-02-21 |
| 2021-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $17.31M derived: sum of 2 quarters · filed 2022-11-02 | $32.25M 10-Q · filed 2022-11-02 | $32.10M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $16.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $31.22M 10-Q · filed 2022-07-27 | $31.07M derived: sum of 3 quarters · filed 2023-02-16 | $30.95M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $14.95M 10-Q · filed 2022-04-27 | $14.79M derived: sum of 2 quarters · filed 2023-02-16 | $14.68M derived: sum of 3 quarters · filed 2023-02-16 | $17.70M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$263.00K derived: sum of 2 quarters · filed 2023-02-16 | $2.75M derived: sum of 3 quarters · filed 2023-02-16 | -$2.17M 10-K · filed 2023-02-16 |
| 2020-09-30 | -$112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $2.90M derived: sum of 2 quarters · filed 2021-10-27 | -$2.02M 10-Q · filed 2021-10-27 | -$274.00K derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$1.91M 10-Q · filed 2021-07-28 | -$162.00K derived: sum of 3 quarters · filed 2022-02-16 | $2.74M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$4.92M 10-Q · filed 2021-04-28 | -$3.18M derived: sum of 2 quarters · filed 2022-02-16 | -$272.00K derived: sum of 3 quarters · filed 2022-02-16 | $878.00K derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $4.65M derived: sum of 2 quarters · filed 2022-02-16 | $5.80M derived: sum of 3 quarters · filed 2022-02-16 | $6.76M 10-K · filed 2022-02-16 |
| 2019-09-30 | $2.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $4.06M derived: sum of 2 quarters · filed 2020-10-29 | $5.02M 10-Q · filed 2020-10-29 | $3.03M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $2.11M 10-Q · filed 2020-07-29 | $124.00K derived: sum of 3 quarters · filed 2021-02-11 | $688.00K derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $963.00K 10-Q · filed 2020-04-29 | -$1.03M derived: sum of 2 quarters · filed 2021-02-11 | -$462.00K derived: sum of 3 quarters · filed 2021-02-11 | $2.64M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$1.43M derived: sum of 2 quarters · filed 2021-02-11 | $1.68M derived: sum of 3 quarters · filed 2021-02-11 | -$1.62M 10-K · filed 2021-02-11 |
| 2018-09-30 | $564.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $3.67M derived: sum of 2 quarters · filed 2019-10-23 | $369.00K 10-Q · filed 2019-10-23 | $4.82M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | -$195.00K 10-Q · filed 2019-07-25 | $4.26M derived: sum of 3 quarters · filed 2020-02-13 | $5.40M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | -$3.30M 10-Q · filed 2019-04-25 | $1.16M derived: sum of 2 quarters · filed 2020-02-13 | $2.30M derived: sum of 3 quarters · filed 2020-02-13 | $7.57M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $4.45M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $5.60M derived: sum of 2 quarters · filed 2020-02-13 | $10.87M derived: sum of 3 quarters · filed 2020-02-13 | $4.08M 10-K · filed 2020-02-13 |
| 2017-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $6.41M derived: sum of 2 quarters · filed 2018-10-23 | -$370.00K 10-Q · filed 2018-10-23 | -$2.91M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $5.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | -$1.51M 10-Q · filed 2018-07-26 | -$4.05M derived: sum of 3 quarters · filed 2019-02-15 | -$59.97M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | -$6.78M 10-Q · filed 2018-04-26 | -$9.32M derived: sum of 2 quarters · filed 2019-02-15 | -$65.25M derived: sum of 3 quarters · filed 2019-02-15 | |
| 2016-12-31 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$58.46M derived: sum of 2 quarters · filed 2019-02-15 | -$58.17M 10-K · filed 2019-02-15 | |
| 2016-09-30 | -$55.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$55.63M 10-Q · filed 2017-10-26 | ||
| 2016-06-30 | $289.00K 10-Q · filed 2017-07-27 | |||
| 2015-12-31 | $40.89M 10-K · filed 2018-02-16 | |||
| 2012-03-31 | $4.57M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-18 | $5.40M derived: sum of 2 quarters · filed 2012-05-18 | $464.85M 10-K · filed 2012-05-18 | |
| 2011-12-31 | $830.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-02 | $460.28M 10-Q · filed 2012-02-02 | ||
| 2011-09-30 | $459.45M 10-Q · filed 2011-11-03 | |||
| 2011-03-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-18 | $3.39M derived: sum of 2 quarters · filed 2012-05-18 | -$40.65M 10-K · filed 2012-05-18 | |
| 2010-12-31 | $628.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-02 | -$43.41M 10-Q · filed 2012-02-02 | ||
| 2010-09-30 | -$44.04M 10-Q · filed 2011-11-03 | |||
| 2010-03-31 | -$23.33M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |